Literature DB >> 21974768

Revisiting evidence of blood pressure-dependent and independent effects of amlodipine on the risk of stroke.

Hisato Takagi, Takuya Umemoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21974768      PMCID： PMC8816485          DOI： 10.1111/j.1751-7176.2011.00485.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  9 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

3.  Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview.

Authors:  Ji-Guang Wang; Yan Li; Stanley S Franklin; Michel Safar
Journal:  Hypertension       Date:  2007-05-14       Impact factor: 10.190

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.

Authors:  B Pitt; R P Byington; C D Furberg; D B Hunninghake; G B Mancini; M E Miller; W Riley
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

6.  Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Peter Libby; Paul D Thompson; Magdi Ghali; Dahlia Garza; Lance Berman; Harry Shi; Ethel Buebendorf; Eric J Topol
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

7.  Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.

Authors:  Pierluigi Costanzo; Pasquale Perrone-Filardi; Mario Petretta; Caterina Marciano; Enrico Vassallo; Paola Gargiulo; Stefania Paolillo; Andrea Petretta; Massimo Chiariello
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

8.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

9.  Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.

Authors:  Toshio Ogihara; Kazuwa Nakao; Tsuguya Fukui; Kohshiro Fukiyama; Kenji Ueshima; Koji Oba; Tosiya Sato; Takao Saruta
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190
  9 in total
  2 in total

1.  Incremental Blood Pressure-Lowering Effect of Titrating Amlodipine for the Treatment of Hypertension in Patients Including Those Aged ≥55 Years.

Authors:  Barrett W Jeffers; Rahul Bhambri; Jeffery Robbins
Journal:  Am J Ther       Date:  2015 Jul-Aug       Impact factor: 2.688

2.  Titration of amlodipine to higher doses: a comparison of Asian and Western experience.

Authors:  Kazuomi Kario; Jeffery Robbins; Barrett W Jeffers
Journal:  Vasc Health Risk Manag       Date:  2013-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.